List of SBIR/STTR awards granted to EMMUNE, INC.
EMMUNE, INC.Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to EMMUNE, INC. in July, 2021 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AI165255-01 | Phase I | 300,000 | July 14, 2021 | |||||||
A SBIR Phase II contract was awarded to EMMUNE, INC. in March, 2022 for $974,663.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44AI165255-02 | Phase II | 974,663 | March 9, 2022 | |||||||
A SBIR Phase I contract was awarded to EMMUNE, INC. in September, 2020 for $292,899.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44TR003501-01 | Phase I | 292,899 | September 1, 2020 | |||||||
A SBIR Phase I contract was awarded to EMMUNE, INC. in August, 2022 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AI170392-01 | Phase I | 300,000 | August 8, 2022 | |||||||
A SBIR Phase II contract was awarded to EMMUNE, INC. in May, 2020 for $886,103.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44AI145491-02 | Phase II | 886,103 | May 19, 2020 | |||||||
A SBIR Phase I contract was awarded to EMMUNE, INC. in January, 2018 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI136163-01 | Phase I | 300,000 | January 15, 2018 | |||||||
A SBIR Phase II contract was awarded to EMMUNE, INC. in August, 2018 for $1,999,634.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44AI134269-02 | Phase II | 1,999,634 | August 27, 2018 | |||||||
A SBIR Phase I contract was awarded to EMMUNE, INC. in August, 2019 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AI145491-01A1 | Phase I | 300,000 | August 1, 2019 | |||||||
A SBIR Phase II contract was awarded to EMMUNE, INC. in March, 2022 for $1,012,172.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44TR003501-02 | Phase II | 1,012,172 | March 1, 2022 | |||||||
A SBIR Phase I contract was awarded to EMMUNE, INC. in August, 2017 for $299,239.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44AI134269-01 | Phase I | 299,239 | August 1, 2017 | |||||||
A SBIR Phase II contract was awarded to EMMUNE, INC. in February, 2017 for $1,935,908.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44AI124832-02 | Phase II | 1,935,908 | February 9, 2017 | |||||||
A SBIR Phase I contract was awarded to EMMUNE, INC. in June, 2015 for $223,934.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI120809-01 | Phase I | 223,934 | June 15, 2015 | |||||||
A SBIR Phase I contract was awarded to EMMUNE, INC. in June, 2016 for $1,235,438.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44AI124832-02 | Phase I | 1,235,438 | June 10, 2016 | |||||||
A SBIR Phase I contract was awarded to EMMUNE, INC. in January, 2023 for $299,998.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AI170285-01A1 | Phase I | 299,998 | January 1, 2023 | |||||||
A SBIR Phase II contract was awarded to EMMUNE, INC. in August, 2023 for $1,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44AI170392-02 | Phase II | 1,000,000 | August 17, 2023 |
